eli lilly is a 'multi-diversified drugmaker', says cantor fitzgerald's louise chen
Published 4 months ago • 2.7K plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
2:49
eli lilly and novo nordisk are ahead in manufacturing but need time to meet demand, says louise chen
-
4:13
cantor fitzgerald's louise chen talks what she's looking for in eli lilly's earnings
-
4:22
fda approves a new alzheimer's drug from eli lilly
-
2:56
eli lilly to offer weight loss drug directly to qualifying customers at lower price
-
5:47
fda advisers say eli lilly alzheimer's treatment is effective
-
6:31
dr. fillit on eli lilly's alzheimer's drug: really having breakthroughs & success for the first time
-
34:06
interview tips with eli lilly
-
1:39
eli lilly song
-
2:40
eli lilly slashes prices of low doses of weight loss drug by scrapping auto-injector
-
2:00
eli lilly is one of our favorites in 2022: bank of america pharma analyst
-
5:29
eli lilly slashes prices of weight-loss drug zepbound for single-use vials
-
3:58
eli lilly hits record high: here's what investors need to know
-
3:14
eli lilly ceo on raising $1b for antibiotic research: goal is to have two to four new antibiotics
-
5:22
eii lilly's weight-loss drug is 'much better' than others on the market, says wells fargo's bansal
-
3:53
eli lilly's alzheimer drug is 'a nice additional therapy', says mizuho's jared holz
-
5:24
eli lilly goes direct-to-consumer on weight loss drugs: what patients and investors need to know
-
3:13
eli lilly ceo: we see a path to an alzheimer's disease-modifying drug
-
5:50
eli lilly ceo: we expect to launch five new medicines in 2022
-
1:32
eli lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
-
4:30
eli lilly ceo on fda approval pathway for alzheimer's drugs
-
1:54
eli lilly to acquire morphic therapeutics for $3.2 billion in cash